Project Grant R21AI178108
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), is providing $450,766 to support research on the molecular mechanisms by which the bacterium Chlamydia trachomatis, the leading cause of sexually transmitted bacterial infections, modulates the function of host cell organelles and their communication to create a favorable intracellular environment for replication....
- This Project Grant award of $145,745 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to investigate how the bacterium Chlamydia trachomatis modulates the host immune response and inflammasome activation. The research aims to understand the mechanism by which a specific Chlamydia protein, CT226, interacts with host proteins LRRFIP1 and FLII to regulate inflammasome activation during...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), provides $431,750 to the University of California, Irvine (UCI) from August 1, 2025 to July 31, 2027. The project aims to develop new complementation tools to enhance the rigor of genetic approaches used to study the function of genes in the Chlamydia trachomatis bacteria, which causes over 1.6 million reported...
- The University of Kentucky Research Foundation was awarded a $423,500 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research CFDA program. The funding will support a 2-year research project to investigate the role of chlamydial polymorphic membrane proteins (PMPs) in the pathogenesis of Chlamydia trachomatis infections, which cause a variety of acute and chronic diseases. The project aims to delineate the specific...
- This Project Grant award of $782,795.00 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to investigate the mechanisms regulating the division process of the bacterium Chlamydia trachomatis, the leading cause of bacterial sexually transmitted infections. The award, with a project period from June 17, 2025 to May 31, 2030, aims to advance the understanding of how this intracellular...
- This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research grant program (CFDA 93.855), provides $156,000.00 to support research on characterizing the process of homotypic fusion in the Chlamydia muridarum (CM) bacterial species. The research aims to understand how this fusion process contributes to the virulence and pathogenesis of Chlamydia infections, a leading cause of sexually transmitted...
- This federal Project Grant award of $214,742 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to identify and characterize Toxoplasma gondii (T. gondii) proteins that facilitate the parasite's ability to cross the placental barrier and cause congenital infection. The research team at Texas A&M University will use innovative in vitro models and pregnant guinea pig studies to test the role...
- The Applied Research Foundation of West Virginia received a $444,000 Project Grant from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research program) to study the effects of stress on Chlamydia infections in a mouse model. The research aims to define the mechanisms by which stress may suppress the immune system and increase the intensity of Chlamydia genital infection and its associated immunopathologies. Key aspects of the project...
- This Project Grant award of $427,604 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to elucidate the molecular mechanisms of conoid extrusion in the pathogen Toxoplasma gondii. The goal is to reconstitute the core elements of the parasite's apical complex, including actin, myosin, and a formin, in vitro to gain a mechanistic understanding of how the conoid structure is extruded...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research (CFDA 93.855) program, provides $244,870 to the University of Washington to evaluate vaccination and antibiotic prophylaxis strategies for preventing Chlamydia trachomatis (CT) infections at the population level. The project aims to 1) assess the frequency and characteristics of antibiotic use among individuals eligible for prophylaxis, and 2)...
ROLE OF PUTATIVE CYTOTOXINS IN CHLAMYDIA INFECTION - ABSTRACT CHLAMYDIA SPECIES ARE IMPORTANT PATHOGENS THAT REPRESENT A PARADIGM FOR UNDERSTANDING SUCCESSFUL OBLIGATE INTRACELLULAR PARASITISM. C. TRACHOMATIS IS A PREVALENT HUMAN PATHOGENS, WHEREAS C. MURIDARUM IS A MURINE-SPECIFIC PATHOGEN OFTEN USED TO STUDY CHLAMYDIAL DISEASE IN A SMALL ANIMAL MODEL. SPECIES-SPECIFIC VARIABILITY IN CODING CAPACITY WITHIN THE SO-CALLED PLASTICITY ZONE OF THE CHLAMYDIAL CHROMOSOME IS THOUGHT TO BE ONE SOURCE DICTATING DIFFERENCES IN INFECTION BIOLOGY. THE PRESENCE/ABSENCE OF GENES ENCODING GLYCOSYLTRANSFERASES DESIGNATED AS PUTATIVE CYTOTOXINS REPRESENTS AN INTRIGUING EXAMPLE OF THIS DIVERSITY. C. MURIDARUM EXPRESS MULTIPLE HOMOLOGOUS PROTEINS THAT ALSO SHOW SIMILARITY TO A FAMILY OF LARGER CYTOTOXINS. THE PLASTICITY ZONE OF COMMON UROGENITAL C. TRACHOMATIS SEROVARS EXPRESS A TRUNCATED PROTEIN WHILE OCULAR SEROVARS OF MEMBERS OF THE LYMPHOGRANULOMA VENEREUM (LGV) BIOVAR LACK THE TOXIN GENES COMPLETELY. THESE CYTOTOXINS HAVE BEEN PROPOSED TO MEDIATE IMMEDIATE TOXICITY IN HIGHLY INFECTED EPITHELIAL CELLS BY INTERFERING WITH ACTIN POLYMERIZATION. LACK OF TRACTABLE GENETICS IN C, MURIDARUM AND UROGENITAL C. TRACHOMATIS, IN PARTICULAR HAS PREVIOUSLY CONFOUNDED DEFINITIVE STUDIES, LEADING TO A PAUCITY IN DETAILS REGARDING MOLECULAR MECHANISMS OF INFECTION. WE HAVE OVERCOME THIS BARRIER BY DELETION OF PUTATIVE CYTOTOXIN GENES IN C. MURIDARUM. OUR DATA INDICATED THAT THESE PROTEINS WERE DISPENSABLE FOR IMMEDIATE TOXICITY. COMBINED WITH ANALYSIS OF C. TRACHOMATIS CT166, OUR DATA IMPLICATE AN ALTERNATIVE FUNCTION FOR THESE PROTEINS. WE PROPOSE TO APPLY GENETIC AND BIOCHEMICAL APPROACHES TO DELINEATE MOLECULAR FUNCTION(S) OF THESE PUTATIVE GLYCOSYLTRANSFERASES AND ADDRESS THEIR CONTRIBUTION(S) TO SPECIES-SPECIFIC INFECTION BIOLOGY.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $186.1k | 6/13/25 | ||
| Not listed | $0 | 8/27/24 | ||
| Not listed | $0 | 8/27/24 | ||
| Not listed | $215.5k | 8/21/24 | ||
| Not listed | $215.5k | 8/21/24 |